Feed aggregator
Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization
Categories: Forest Products Industry
Gossamer Bio, Inc. (GOSS) Stock Jumps 18% on FDA Updates and Seralutinib Progress
Categories: Forest Products Industry
Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203
Categories: Forest Products Industry
Galectin Therapeutics Inc. (GALT) Surges on Promising Belapectin Trial Data and Strong Financials
Categories: Forest Products Industry
Atai Life Sciences N.V. (ATAI) Advances Psychedelic Therapies for Mental Health, Drawing Investor Spotlight
Categories: Forest Products Industry
MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand
Categories: Forest Products Industry
I-Mab (IMAB) Shows 83% Response Rate for Givastomig in Metastatic Gastric Cancer
Categories: Forest Products Industry
ABVC BioPharma, Inc. (ABVC) Reports 103% Asset Surge, Eyeing Phase III Trials for Depression Therapies
Categories: Forest Products Industry
Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval
Categories: Forest Products Industry
Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up
Categories: Forest Products Industry
Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth
Categories: Forest Products Industry
Viatris Inc. (VTRS) Gains FDA Approval for First Generic Iron Sucrose Injection
Categories: Forest Products Industry
Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies
Categories: Forest Products Industry
Powering AI: From CERA Week Optimism to New York Climate Week Realism
Categories: Forest Products Industry
Stock market today: Nasdaq, Dow, S&P 500 waver with divided Fed, Alibaba in focus
Categories: Forest Products Industry
EMA Gives Positive Opinion on Zoetis Inc. (ZTS)’ Cat Arthritis Therapy, Portela
Categories: Forest Products Industry
Merck & Co., Inc. (MRK) Received FDA Approval For Keytruda Qlex, Cutting Infusion Time to 2 Minutes
Categories: Forest Products Industry
Bristol-Myers Squibb Company (BMY) to Divest 60% China JV Amid Strategic Realignment
Categories: Forest Products Industry
Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis
Categories: Forest Products Industry
Eli Lilly and Company (LLY) Unveils $5B Virginia Facility to Ramp Up Bioconjugate and Monoclonal Antibody Production
Categories: Forest Products Industry
Pages
